Sir David Jack | |
|---|---|
&sq=Facebook&lang=en&file=File:David_Jack_(pharmacologist).jpg) | |
| Born | 22 February 1924 |
| Died | 8 November 2011 (aged 87) |
| Citizenship | British |
| Alma mater | |
| Known for | Drug discovery and development |
| Spouse | Lydia Downie Brown (1952–2016) |
| Awards |
|
| Scientific career | |
| Fields | Pharmacology, Medicinal chemistry |
| Institutions | Allen & Hanburys, Glaxo |
| Doctoral advisor | Arnold Beckett |
Sir David Jack (22 February 1924 – 8 November 2011[2][3]) was a Scottish pharmacologist and medicinal chemist who specialised in the development of drugs for treating asthma. He was head of research and development at Glaxo from 1978 until 1987.
- ^ Breckenridge, S. Alasdair (2014). "Sir David Jack. 22 February 1924 -- 8 November 2011". Biographical Memoirs of Fellows of the Royal Society. 60: 249–260. doi:10.1098/rsbm.2014.0006.
- ^ "Sir David Jack". The Daily Telegraph. 17 November 2011. Retrieved 25 November 2011.
- ^ "Sir David Jack". The Herald. 19 November 2011.